This combination therapy is supported by NICE NG28 guidance for treatment intensification when glycaemic targets are not achieved with single agents
When stimulated, these L-cells release more GLP-1 into your system
Regulatory approval processes for new indications, such as cardiovascular and obesity treatments, often require extensive clinical trials involving thousands of participants, leading to extended timelines
Therefore, their biological relevance in vivo remains uncertain and requires further investigation
Within experimental models, TB-500 is commonly studied for its association with wound healing, tissue repair, and angiogenesis
Its prolonged presence in the body helps control appetite, promoting weight loss and maintaining stable blood sugar levels